Buy Gsk Shares -

AI responses may include mistakes. For financial advice, consult a professional. Learn more Why is everyone buying GSK shares? | The Motley Fool UK

: Despite the recent price rally, GSK still trades at a modest price-to-earnings (P/E) ratio of roughly 14–15x , which some analysts consider undervalued compared to global peers. Income Potential: Dividends buy gsk shares

GSK remains a staple for income-seeking investors, with management showing a commitment to increasing payouts: AI responses may include mistakes

: Major product approvals are expected in 2026 for Bepirovirsen (Chronic Hepatitis B) and Tebipenem (UTIs). buy gsk shares

: 2025 revenue hit £32.7bn (up 7%), driven by high-margin specialty medicines like HIV and Respiratory treatments.